产品简要
公司名称 :
DIMA Biotechnology
产品类型 :
抗体
产品名称 :
Anti-CD38 (daratumumab biosimilar) mAb
目录 :
BME100004
规格 :
50微升, 100微升
价格 :
80美元, 160美元
克隆性 :
单克隆
宿主 :
humans
共轭标签 :
未共轭
克隆名称 :
BME100004
反应物种 :
人类
应用 :
酶联免疫吸附测定, 流式细胞仪
更多信息或购买 :
图像
图像 1 :
DIMA Biotechnology BME100004 图像 1
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD38, hFc-His tagged protein (PME100004) can bind Anti-CD38 Neutralizing antibody in a linear range of 0.98-64.14 ng/ml.
图像 2 :
DIMA Biotechnology BME100004 图像 2
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD38(A) were surface stained with anti-CD38 neutralizing antibody 1μg/ml (daratumumab) followed by Alexa 488-conjugated anti-rabbit IgG secondary antibody.
图像 3 :
DIMA Biotechnology BME100004 图像 3
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD38(A) were surface stained with anti-CD38 neutralizing antibody 1μg/ml (daratumumab) followed by Alexa 488-conjugated anti-rabbit IgG secondary antibody.
产品信息
目录代码 :
BME100004
产品名称 :
Anti-CD38 (daratumumab biosimilar) mAb
产品类型 :
抗体
宿主物种 :
克隆性 :
单克隆
共轭 :
未共轭
抗原修饰 :
no modification
克隆名称 :
BME100004
抗体亚型 :
IgG1
照明链 :
kappa
规格 :
50微升, 100微升
标价 :
80美元, 160美元
产品描述 :
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
物种摘要 :
人类
免疫原 :
CD38
特异性 :
ELISA, Flow Cyt
纯度 :
Purified from cell culture supernatant by affinity chromatography
缓冲液 :
50% 甘油;PBS, pH值7.4;0.1% BSA
防腐剂 :
0.1% ProClin防腐剂300
包装 :
10微升/100微升
用途 :
研究美国只有
应用摘要 :
ELISA 1:4000, Flow Cyt 1:100
储存 :
Store at -20°C (Avoid repeated freezing and thawing)
更多信息或购买 :
公司信息
DIMA Biotechnology
Wuhan institute of Biotechnology B7
Biolake No.666 Gaoxin Road
Wuhan, Hubei
info@dimabio.com
https://www.dimabio.com
0118615307149771
公司总部: 中国
DIMA BIOTECH LTD (DIMABIO) focuses exclusively on the pre-clinical research market of Immune Oncology. Currently, we offer functional proteins and recombinant monoclonal antibodies. Our proprietary DimAb™ technology platform can directly clone IgG gene from immunized animal, which is a technology breakthrough in monoclonal antibody development.

All DIMABIOs protein products were manufactured by using mammalian cell expression system. To analyze the function of DIMABIOs proteins, we evaluated them by paired binding test between native ligand-receptor and or the binding capacity to the therapeutic antibodies. For DimAb™ recombinant monoclonal antibodies, we focus mainly on identifying clones with flow and blocking activity.